Shenyang Sunshine Pharmaceutical Co., Ltd.
Clinical trials sponsored by Shenyang Sunshine Pharmaceutical Co., Ltd., explained in plain language.
-
New drug combo trial offers hope for advanced gastrointestinal cancers
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called SSGJ-706 to standard first-line chemotherapy is safe and effective for people with advanced cancers of the digestive system. It will enroll about 300 adults with advanced stomach, colorectal, pancreatic, or esophage…
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New bladder cancer treatment enters human testing
Disease control Not yet recruitingThis early-stage clinical trial is testing a new drug called SPGL008, both by itself and combined with an existing treatment (BCG), for people with high-risk non-muscle-invasive bladder cancer. The main goals are to find a safe dose and see if the treatment shows early signs of h…
Phase: PHASE1, PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC